BIOMEDICA CROBIOMEDICA CRO
  • +38 (068) 150 70 04
  • office@biomedica-cro.com
  • Biospecimens
    • Tissue Samples
    • Blood Samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
    • BIOMEDICA CRO in Scientific Publications
  • Contacts
  • ENEN
    • UAUA
Search
SEND REQUEST
  • Biospecimens
    • Tissue Samples
    • Blood Samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
    • BIOMEDICA CRO in Scientific Publications
  • Contacts
  • Home
  • Blog
  • 🧬 9 Years of Biospecimen Collection: 395,000+ Human Biospecimens and 48,000+ Patients

🧬 9 Years of Biospecimen Collection: 395,000+ Human Biospecimens and 48,000+ Patients

🧬 9 Years of Biospecimen Collection: 395,000+ Human Biospecimens and 48,000+ Patients

15.09.2026
BIOMEDICA CRO provides high-quality human biospecimens through prospective biospecimen collection and banked inventory, supporting biomedical research worldwide.
admin2026-09-15T14:13:43+00:00

For the past 9 years, BIOMEDICA CRO has been supporting pharmaceutical, biotechnology, diagnostic, and academic research with high-quality biospecimen collection through our network of clinical sites in Ukraine.

Since 2017, our team has continuously expanded its experience in patient recruitment, biosample collection, sample processing, clinical data management, and logistics. Today, our growing numbers demonstrate the scale of our work:

📊 Our Key Milestones

  • 🧬 395,000+ human biospecimens collected
  • 👥 48,000+ patients recruited
  • 📅 9 years of experience in human sample collection and procurement
  • 🧪 48,000+ banked biospecimens available in inventory
  • 🏥 50+ partnered clinical sites

These milestones reflect not only the number of samples collected, but also years of collaboration with physicians, clinical sites, researchers, pharmaceutical companies, biotechnology companies, and diagnostic organizations.

🔬 A Trusted Biospecimen Provider with 9 Years of Experience

At BIOMEDICA CRO, we provide banked human biospecimens and prospective biospecimen collection tailored to each research project’s needs.

Our experience covers a broad range of therapeutic areas, including oncology, autoimmune and inflammatory diseases, neurological disorders, infectious diseases, metabolic conditions, and other clinical indications.

🧪 Depending on the study requirements, available biospecimens may include:

  • 🩸 Whole blood
  • 🧫 Plasma and serum
  • 🔬 Buffy coat
  • 🧬 PBMCs
  • 🧪 FFPE tissue
  • ❄️ Fresh-frozen tissue or viably frozen tissue
  • 💧 Saliva and urine
  • 🧫 Swabs
  • 🧪 Other human biofluids and customized sample types

Our approach combines access to patients with direct coordination of clinical sites and physicians. This allows us to support projects where researchers require specific inclusion and exclusion criteria, defined sample volumes, particular processing conditions, matched biospecimens, or associated clinical information.

🔬 Prospective Biospecimen Collection and Available Biosamples from the Inventory

🧬 Prospective Collection

When the required biospecimens are not currently available in our inventory, BIOMEDICA CRO can organize prospective sample collection based on the specific requirements of your research project.

Our team works with a network of 50+ clinical sites and physicians to identify and recruit suitable patients, coordinate sample collection according to the study protocol, and manage sample processing, clinical data collection, and shipment.

Prospective collection can be tailored to specific:
✅ Disease indications and patient populations
✅ Sample types and required volumes
✅ Clinical and demographic criteria
✅ Collection and processing protocols
✅ Required clinical data and testing
✅ Recruitment targets and timelines

This approach allows researchers to obtain study-specific human biospecimens that may not be available as banked samples, with the collection process designed around the requirements of the project.

 

🧪 48,000+ Banked Biospecimens Available for Research

For projects where available biosamples are required, our growing inventory can provide a faster alternative to initiating a new prospective collection.

BIOMEDICA CRO currently has 48,000+ available biosamples for research across a range of sample types and clinical indications. Researchers can explore the inventory using available filters, including disease indication, specimen type, and other relevant characteristics, to identify potentially suitable samples.

🔍 Looking for available biospecimens? Explore our inventory by clicking here.

Once you identify a potentially suitable selection, simply share it with our team. We can then review the requested samples and confirm availability, pricing, sample details, and project-specific options.

🌍 One Coordinated Biospecimen Research Service

Whether you need ready-to-ship banked biospecimens or a custom prospective collection, BIOMEDICA CRO is here to assist you. With 9 years of experience, we continue to expand our capabilities and support biomedical, pharmaceutical, biotechnology, and diagnostic research projects with human biospecimens & clinical data.

📩 Looking for specific human biospecimens or considering a custom collection? Contact us at office@biomedica-cro.com to discuss your study requirements, inventory availability, prospective collection feasibility, pricing, and timelines.

🚀 Stay connected on LinkedIn for updates on biospecimen availability, research collaborations, and industry insights 📊.

📩 Place your Request for High-Quality Human Biospecimens TODAY!📩

Share this post

Facebook Twitter LinkedIn
All publications
Human Serum Biospecimens Support Research into Vascular Microcalcification and Cardiovascular Risk 🔬
  • Biospecimens
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts

Privacy Policy | Terms of use

Linkedin

Site development mamontova design

BIOMEDICA CRO
© 2026 | All rights reserved

View the Inventory

Click on the button "Download the inventory" to review the list of ready-to-ship biospecimens.

Download the Inventory
have any questions?

Send request

Fill out the form and we will contact you shortly

    Name

    E-mail

    Your message




    have any questions?

    Send request

    Please send us a message and we’ll be back to you shortly

      Name

      Company name

      E-mail

      Your message

      Iryna Iurkova

      Business Development Director

      Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.

      Ostap Kupnovitsky - PhD, MD, MBA, BIOMEDICA CRO Co-Founder, Chairman of the Supervisory Board

      Ostap Kupnovitsky

      PhD, MD, MBA,
      BIOMEDICA CRO Co-Founder,
      Chairman of the Supervisory Board

      Dr. Kupnovitsky has a vast experience in the pharmaceutical market. He was the Regional Director of Organon and Serono in Ukraine. In 2003, he became a Co-Founder and Director of Sona-Pharm, the firm that started its activity in Ukraine and has flourished into an international marketing company with its representatives throughout the CIS region. Since 2017, when BIOMEDICA CRO was founded, he has been a distinguished Chairman of its Supervisory Board.

      Anton Zubov - MD, BIOMEDICA CRO Co-Founder, Board Member

      Anton Zubov

      MD, BIOMEDICA CRO Co-Founder,
      Board Member

      Dr. Zubov has over 21 years of experience in the international pharmaceutical markets. He has held numerous leading positions in marketing, management and sales at Schering AG and Bayer Pharmaceuticals. He has made a career internationally with positions in Ukraine, Germany and Central Asia. In 2017, together with Dr. Kupnovitsky, he founded BIOMEDICA CRO and during the first years was its CINO. Dr. Zubov is currently a Marketing & Sales Director of the CIS Region in Farmak and Board Member of BIOMEDICA CRO Supervisory Board.

      Serhii Samsoniuk

      Chief Executive Officer

      Mr. Samsoniuk is a pharmaceutical expert with over 15 years of industry experience. Over the course of his career, he has held key leadership roles at both international and local companies, such as GlaxoSmithKline, B.Braun, and Sona Exim, overseeing strategic marketing, sales, and key account management. Before joining BIOMEDICA CRO team, he led business development efforts in the CCA+ region at Farmak, driven by a commitment to professional ethics and strategic partnership.